Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Benzene sulfonamide derivatives, preparation method, and treatment application

A technology of benzenesulfonamide and derivatives, which is applied in the field of medicine and can solve problems such as high toxicity

Inactive Publication Date: 2015-03-11
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Wortmannin and LY294002 are the first-generation PI3K inhibitors. These two inhibitors are not selective for PI3K, so they are more toxic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzene sulfonamide derivatives, preparation method, and treatment application
  • Benzene sulfonamide derivatives, preparation method, and treatment application
  • Benzene sulfonamide derivatives, preparation method, and treatment application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] N-(5-(4-(3-(dimethylamino)prop-1-yn-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)-2,4 - Difluorobenzenesulfonamide (III, compound number in the table 1 ) preparation

[0063]

[0064] a) Preparation of N-(5-(4-chloroquinolin-6-yl)-2-methoxypyridin-3-yl)-2,4-difluorobenzenesulfonamide (II)

[0065] Dissolve 6-bromo-4-chloroquinoline (2 g, 8.25 mmol) in dioxane (30 mL), add pinacol diborate (2.30 g, 9.07 mmol) and potassium acetate (1.62 g, 16.50 mmol ) and the palladium catalyst PdCl 2 (dppf)CH 2 Cl 2 (0.21g, 0.25mmol), heated to reflux at 100°C for 3h under the protection of nitrogen, the raw material point was detected to disappear, and the reaction was stopped. Add N-(5-bromo-2-methoxypyridin-3yl)-2,4-difluorobenzenesulfonamide (I) (3.4 g, 9.08 mmol) and another part of palladium catalyst PdCl to the mixed system 2 (dppf)CH 2 Cl 2 (0.21 g, 0.25 mmol) and 2M K 2 CO 3 solution (10 mL), heated to reflux at 110° C. for 16 h under nitrogen protection to stop the ...

Embodiment 2-11

[0069] surface 1 Compound 2-11 Can be by corresponding raw material, with reference to preparation embodiment 1 Compounds were prepared by general methods.

Embodiment 12

[0070] Example 12 : The enzyme inhibitory activity assay of this series of compounds:

[0071] The test results of the enzyme inhibitory activity of the above-mentioned compounds are shown in the table 3 , a total of three methods were used in the test:

[0072] Using the method of Lance Ultra Assay to test the IC of mTOR 50 value.

[0073] Using the method of ADP-Glo ​​Luminescent Kinase Assay to test the IC of PI3Kβ and PI3Kγ 50 value.

[0074] Use the method of Kinase-Glo Luminescent Kinase Assay to test the IC of PI3Kα and PI3Kδ 50 value.

[0075] Table 3 IC of some compounds on PI3Kα 50 (nM)

[0076]

[0077] Table 3 It can be seen that all the synthesized compounds have good inhibitory activity on PI3Kα, the best of which is the compound 3 , is 2.0 nM. On this basis, two compounds with better activity were preferred, and their inhibitory activities on mTOR and different subtypes of PI3K were tested, and it was shown that they had inhibitory activit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicine, and specifically relates to benzene sulfonamide derivatives in different substitution types, wherein the derivatives are represented by the formula (A), and the definitions of each group are listed in the description. The derivatives have an excellent performance on inhibiting the activity of PI3K kinase, and moreover have high antitumor activities on tumors such as human lung cancer, human colon cancer, human liver cancer, human breast cancer, and the like. So the derivatives can be used to prepare target antitumor drugs having the advantages of high efficiency, low toxicity, and strong specificity, and thus the derivatives have very good development values. The invention further relates to a composition composed of the derivatives, a preparation method thereof, and applications of the composition in preparation of antitumor drugs.

Description

technical field [0001] The invention relates to the technical field of medicine, and relates to a class of various types of substituted benzenesulfonamide derivatives, a preparation method and a composition. The present invention also relates to the use of such compounds in the preparation of therapeutic drugs for one or more of the following diseases: autoimmune diseases, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergies, asthma, pancreatitis , multiple organ failure, kidney disease, platelet aggregation, cancer, sperm motility, transplant rejection, graft rejection, and lung injury, especially cancer. Such compounds exhibit good broad-spectrum inhibitory activity against various tumor cells such as human lung cancer, colon cancer, breast cancer, and liver cancer. Background technique [0002] In recent years, malignant tumors have become the first cause of death among urban and rural residents in my country, and the mortality rate is in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/04C07D401/14A61K31/4709A61K31/496A61K31/5377A61P35/00A61P37/06A61P29/00A61P9/00A61P25/28A61P37/08A61P11/06A61P13/12A61P1/18A61P7/02A61P15/08A61P11/00
CPCC07D401/04C07D401/14
Inventor 朱驹宋云龙陈颖杨超张懿田巍王重庆蒋骏航刘婷章玲周有骏吕加国
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products